Leadership
Brian Tinkham
President, Chief Executive Officer
As an invited speaker and faculty for multiple U.S. and international GI and Surgical societies, Brian is recognized as a leader in innovation and entrepreneurship. He was the co-founder of Beacon Endoscopic, acquired by Covidien 2014. GI Windows being a spin out of Beacon. He has held significant roles at Medtronic as Vice President of New Technologies and VP of Sales for the GI & Hepatology division. He also held global marketing and sales leadership positions at Boston Scientific.
Peter Lukin
Chief Operating Officer
Peter has over two decades of experience in new product development, operations, and general management of interventional endoscopic instruments and glucose sensors. Most recently he served as Vice President of Operations for Beacon Endoscopic (acquired by Covidien 2014). Prior, he was responsible for over 15 commercial product launches of biliary, tissue acquisition, enteral feeding and hemostasis endoscopic technologies.
Gerry Sheridan
Chief Financial Officer
Gerry is Chief Financial Officer of GI Windows and his responsibilities include all aspects of financial management of the Company. He brings to the role over 20 years of global financial management experience. Prior to joining GI Windows he has held senior leadership roles principally in medical device startups. Earlier in his career, Gerry held senior-level positions in public accounting as an auditor and a transaction advisory consultant. Gerry holds a Bachelor of Commerce from University College Dublin, and he is also a member of the AICPA as well as being a Fellow of the Institute of Chartered Accountants in Ireland.
Dr. Erik B. Wilson, MD
Chief Medical Officer
Dr. Erik B. Wilson, MD, is a distinguished surgeon and academic leader based in Houston, Texas. He serves as a Professor in the Department of Surgery at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) and holds the position of Division Chief of Elective General Surgery. Dr. Wilson's contributions to the field of surgery, particularly in minimally invasive and robotic-assisted procedures, have been recognized on a global scale, solidifying his reputation as a leader in surgical innovation and education. He has been instrumental in advancing minimally invasive surgical techniques throughout the world.
Yverre Bobay
Vice President of Regulatory
Yverre is a medical device professional with over 20 years of global regulatory experience and proven leadership in class II and III devices, including weight loss technologies and implantable medical devices. She has significant experience with FDA, including PMAs, 510(k)s, and IDEs. She’s obtained additional global product approvals in Europe, Canada, Brazil, China, Australia, and other ROW countries. She has earned a Bachelor of Science in Biology from the University of California, San Diego, and a Master’s in Public Health in Epidemiology from the University of Utah.
Board of Directors
Anita S Watkins
Board Observer
Managing Director Rex Health Ventures
Anita is the Managing Director for Rex Health Ventures (RHV), the corporate venture fund of UNC Health, the largest academic health system serving the state of North Carolina. She currently serves as a Director or Observer on the boards of Bio54, ReDiscovery Life Sciences, Vergent Bioscience, and Censinet. Anita supports and advises companies on successful commercial pathways, effective partnerships with health systems and the business of health care. As an Eisenhower Fellow, she evaluated targeted funding and public policy initiatives bolstering female entrepreneurs in Chile and Spain. She was also selected as a member of OnBoardNC, an organization started by the former State Treasurer to advance diversification of board directors, serves on the NCSU Chancellor’s Innovation Fund Board, and has served as Chair of the Board of the Natural Sciences Museum. She is a graduate of NC State University and holds a law degree and a masters from the University of North Carolina.
Steve Burriss
Director
Orlando Health Chief Operating Officer
As chief operating officer, Steve Burriss works collaboratively with the executive team, governing board and medical staff to develop and implement strategic plans for the organization. He provides leadership and direction for all programs, services and staff for the hospital facilities, actively driving a culture of clinical excellence, service excellence and patient safety in all areas. Prior to joining Orlando Health, Steve held progressive leadership positions with UNC Health, a leading academic healthcare system based in Chapel Hill, North Carolina. Most recently, he was chief operating officer and president of UNC Health Network Hospitals.
John Cammett
Director
Co-Founder Realterm Private Equity
Mr. Cammett, a lifelong entrepreneur, is the co-founder of Realterm Private Equity Fund, which now represents over $8BN in assets through five logistics-oriented equity fund series. John now sits on the Executive Management Committee of Realterm and the Investment Committees of the Funds.
Mr. Cammett has extensive experience investing in the Life Science sector. John is the major shareholder and a board member of several MedTech & Biotech companies. John graduated from Harvard with an AB in Engineering and Applied Sciences.
Payson Coleman, Esq
Director
Senior Counsel, Pillsbury
Payson is highly experienced with privately held companies, private equity and non-profits. He offers extensive legal and investment expertise as well as broad experience and critical thinking outside of the medical device and healthcare industries to compliment the other GI Windows board members.
V. Kadir Kadhiresan, PhD
Director
Vice President, Venture Investments
Johnson & Johnson Innovations
Based in Boston, Kadir works closely with Johnson & Johnson leadership to identify business needs and has responsibility for sourcing, investing and managing venture investment opportunities. He holds board seats for several JJDC portfolio companies. Some of his investments include Coherex Medical (Acquired by Biosense Webster/JNJ), Spinal Modulation (Acquired by St.Jude/ABT), Novocure (NASDAQ: NVCR), Torax Medical (Acquired by Ethicon/JNJ), Neotract (Acquired by Teleflex) and Inspire Medical Systems (NYSE: INSP).
Frederic Moll, MD
Director
Sonder Capital, Co-Founder & Partner
Dr Moll brings both clinical and business expertise to augment and compliment the GI Window's board. He is globally recognized as the Founder of Robotics in healthcare. Prior to J&J, Dr. Moll co-founded Auris Health (acquired by J&J, $5.7B) and served as Chief Executive Officer. Earlier in his career, Dr. Moll has founded and led several Medtech companies including co-founder of Intuitive Surgical Inc. (Stock ISRG), serving as its first Chief Executive Officer.
Yuriy Onyskiv
Board Observer
Managing Director at Orlando Health Ventures
Yuriy Onyskiv is a Principal at Orlando Health Ventures, and leads investment efforts for the healthcare system. Yuriy leads investing efforts across medtech, biotech, and digital solutions in healthcare. He has over 15 years of experience in venture capital, finance, and mergers & acquisitions. Previously, he was a pre-seed and seed stage investor for digital health businesses and supported financial restructuring efforts across a variety of large healthcare systems. Yuriy holds a Bachelor’s Degree from the University of Wisconsin - Madison and a Master’s Degree from the London School of Economics & Political Science.
Peter Rogal
Board Observer
CEO, Gold Circuit Electronics Global Sales and Services LLC
Peter has over 40 years of experience in the high tech electronics industry and as a serial entrepreneur and business executive. He has invested and maintains board seats in several rapidly growing Life Science companies. He is the founder and 100% shareholder of Brooktrout Ventures, a small to midsized angel investing firm.
Daniel T. Sheehan
Director
Vice President of Venture Capital, Medtronic
Dan manages the activities of Medtronic Ventures, Medtronic’s Corporate Venture Capital investment group. He began Corporate Venture investing in 2008, and since that time his teams have made investments in over 50 healthcare and medical technology companies. Dan has served on several portfolio company boards and is passionate about working with managers and investors in emerging companies. Prior to Medtronic, he was a General Partner with Affinity Capital Management, a healthcare-oriented venture capital firm. He has also managed the business development and strategic marketing efforts for Steris Corporation. He is a graduate of Fordham University and Columbia Business School
Christopher Thompson, MD
Director
Director of Endoscopy, Brigham & Women’s Hospital
Professor of Medicine, Harvard Medical School
Dr. Thompson is the co-founder of Beacon Endoscopic and GI Windows. He is one of the seminal international thought leaders in the rapidly emerging new fields of Natural Orifice Transluminal Endoscopic Surgery (NOTES) and Bariatric Endoscopy.
Dr. Thompson received his MD degree from Pennsylvania State University College of Medicine and completed advanced Clinical and Research fellowships at Harvard Medical School.